See more : Mach7 Technologies Limited (M7T.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Magellan Health, Inc. (MGLN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Magellan Health, Inc., a leading company in the Medical – Healthcare Plans industry within the Healthcare sector.
- Valneva SE (VLA.PA) Income Statement Analysis – Financial Results
- Croda International Plc (COIHF) Income Statement Analysis – Financial Results
- Vanoil Energy Ltd. (VNLEF) Income Statement Analysis – Financial Results
- Umicore SA (UMI.BR) Income Statement Analysis – Financial Results
- Hanstone Gold Corp. (HANCF) Income Statement Analysis – Financial Results
Magellan Health, Inc. (MGLN)
About Magellan Health, Inc.
Magellan Health, Inc., together with its subsidiaries, provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans; and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Further, it offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions. In addition, the company provides services to health plans and managed care organizations, employers, labor unions, third party administrators, state governments, military and governmental agencies, exchanges, brokers, and consultants. Magellan Health, Inc. was incorporated in 1969 and is headquartered in Phoenix, Arizona. As of January 4, 2022, Magellan Health, Inc. operates as a subsidiary of Centene Corporation.
Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4.58B | 7.16B | 7.31B | 5.84B | 4.84B | 4.60B | 3.76B | 3.55B | 3.21B | 2.80B | 2.97B | 2.64B | 2.63B | 2.16B | 1.69B | 1.81B | 1.80B | 1.51B | 445.89M | 1.76B | 1.87B | 1.87B | 1.51B | 1.21B | 1.35B | 1.15B | 904.65M |
Cost of Revenue | 4.46B | 6.93B | 7.12B | 5.57B | 4.58B | 4.42B | 3.55B | 3.31B | 2.96B | 2.02B | 2.13B | 2.43B | 2.44B | 1.96B | 1.51B | 1.57B | 0.00 | 1.32B | 0.00 | 1.56B | 1.65B | 1.66B | 1.29B | 978.51M | 0.00 | 0.00 | 0.00 |
Gross Profit | 118.79M | 229.29M | 197.18M | 271.02M | 258.94M | 178.38M | 215.08M | 238.19M | 249.58M | 782.64M | 842.63M | 207.46M | 186.87M | 193.26M | 181.90M | 241.62M | 1.80B | 185.86M | 445.89M | 198.47M | 220.97M | 208.01M | 217.97M | 232.18M | 1.35B | 1.15B | 904.65M |
Gross Profit Ratio | 2.60% | 3.20% | 2.70% | 4.64% | 5.35% | 3.88% | 5.72% | 6.72% | 7.78% | 27.96% | 28.38% | 7.85% | 7.12% | 8.96% | 10.76% | 13.36% | 100.00% | 12.30% | 100.00% | 11.31% | 11.79% | 11.11% | 14.41% | 19.18% | 100.00% | 100.00% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.59B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 876.61M | 822.39M | 723.50M | 619.55M | 557.51M | 529.63M | 566.58M | 0.00 | 0.00 | 0.00 | 0.00 | 15.81M | 1.59B | 0.00 | 391.43M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Expenses | 98.39M | 131.51M | 132.66M | 115.71M | -770.57M | -719.55M | -632.43M | -547.55M | -497.02M | 58.62M | 54.68M | 47.27M | 60.81M | 57.52M | 48.86M | 49.09M | 42.49M | 358.06M | 14.38M | 35.07M | 91.02M | 63.79M | 103.54M | 163.71M | 1.23B | 1.15B | 922.79M |
Operating Expenses | 98.39M | 131.51M | 132.66M | 115.71M | 106.05M | 102.84M | 91.07M | 71.99M | 60.49M | 588.26M | 621.26M | 47.27M | 60.81M | 57.52M | 48.86M | 64.90M | 1.63B | 358.06M | 405.81M | 35.07M | 91.02M | 63.79M | 103.54M | 163.71M | 1.23B | 1.15B | 922.79M |
Cost & Expenses | 4.56B | 7.06B | 7.25B | 5.68B | 4.68B | 4.52B | 3.64B | 3.38B | 3.02B | 2.61B | 2.75B | 2.48B | 2.50B | 2.02B | 1.56B | 1.63B | 1.63B | 1.68B | 405.81M | 1.59B | 1.74B | 1.73B | 1.40B | 1.14B | 1.23B | 1.15B | 922.79M |
Interest Income | 4.05M | 19.19M | 14.07M | 5.89M | 2.82M | 2.17M | 1.30M | 1.99M | 2.02M | 2.78M | 3.28M | 6.25M | 17.03M | 23.84M | 17.63M | 17.46M | 6.13M | 2.87M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 30.87M | 36.15M | 35.40M | 25.98M | 10.19M | 6.58M | 7.39M | 3.00M | 2.25M | 2.50M | 2.23M | 2.42M | 2.85M | 6.39M | 7.29M | 44.01M | 37.12M | 61.02M | 873.00K | -8.80M | -83.00M | -18.41M | -38.31M | -14.36M | -6.16M | 0.00 | -12.62M |
Depreciation & Amortization | 118.75M | 131.51M | 132.66M | 115.71M | 106.05M | 102.84M | 91.07M | 71.99M | 60.49M | 58.62M | 54.68M | 47.27M | 60.81M | 57.52M | 48.86M | 49.09M | 42.49M | 48.05M | 14.38M | 70.28M | 79.24M | 73.53M | 54.89M | 44.86M | 48.92M | 64.09M | 59.55M |
EBITDA | 487.41M | 248.48M | 211.25M | 276.97M | 263.85M | 183.25M | 221.55M | 240.18M | 251.60M | 255.79M | 279.32M | 213.70M | 203.90M | 216.74M | 205.11M | 306.09M | 214.57M | 594.65M | 29.24M | 131.22M | 28.91M | 105.60M | 55.64M | 53.60M | 107.00M | 9.82M | -10.60M |
EBITDA Ratio | 10.65% | 3.47% | 2.89% | 4.74% | 5.45% | 3.99% | 5.89% | 6.77% | 7.84% | 9.14% | 9.41% | 8.09% | 7.77% | 10.05% | 12.13% | 16.93% | 11.95% | 39.36% | 6.56% | 7.47% | 1.54% | 5.64% | 3.68% | 4.43% | 7.95% | 0.85% | -1.17% |
Operating Income | 368.67M | 116.97M | 78.59M | 161.27M | 157.80M | 80.40M | 130.48M | 168.19M | 191.11M | 197.16M | 224.64M | 166.43M | 143.09M | 159.21M | 156.25M | 257.00M | 172.08M | 546.60M | 14.86M | 60.94M | -50.33M | 32.06M | 750.00K | 8.74M | 58.08M | -54.27M | -70.16M |
Operating Income Ratio | 8.05% | 1.63% | 1.07% | 2.76% | 3.26% | 1.75% | 3.47% | 4.74% | 5.96% | 7.04% | 7.57% | 6.30% | 5.45% | 7.38% | 9.24% | 14.21% | 9.58% | 36.18% | 3.33% | 3.47% | -2.69% | 1.71% | 0.05% | 0.72% | 4.32% | -4.71% | -7.75% |
Total Other Income/Expenses | -409.15M | -36.15M | -35.40M | -26.04M | -12.28M | -9.29M | -12.56M | -3.00M | -2.25M | -2.50M | -2.23M | -2.42M | -2.85M | -6.03M | -7.33M | -45.54M | -40.54M | -60.82M | -873.00K | 8.80M | 83.00M | 18.41M | 38.31M | 14.36M | 6.16M | 0.00 | 12.62M |
Income Before Tax | -40.49M | 80.82M | 43.19M | 135.22M | 145.52M | 71.12M | 117.92M | 165.19M | 188.87M | 194.66M | 222.40M | 164.01M | 140.24M | 153.19M | 148.92M | 211.46M | 131.54M | 485.78M | 13.99M | 69.74M | 32.67M | 50.47M | 39.06M | 23.10M | 64.24M | -54.27M | -57.54M |
Income Before Tax Ratio | -0.88% | 1.13% | 0.59% | 2.32% | 3.01% | 1.55% | 3.14% | 4.66% | 5.89% | 6.95% | 7.49% | 6.21% | 5.34% | 7.11% | 8.81% | 11.70% | 7.33% | 32.16% | 3.14% | 3.97% | 1.74% | 2.70% | 2.58% | 1.91% | 4.78% | -4.71% | -6.36% |
Income Tax Expense | -44.53M | 24.92M | 19.01M | 25.08M | 69.73M | 42.41M | 43.69M | 39.92M | 37.84M | 65.04M | 83.74M | 57.34M | 54.04M | 58.67M | 62.70M | 82.41M | 46.58M | 33.81M | 3.13M | 36.39M | 15.48M | 27.38M | 20.03M | 9.24M | 25.70M | -11.31M | -10.54M |
Net Income | 4.05M | 55.90M | 24.18M | 110.14M | 75.79M | 28.71M | 74.23M | 125.26M | 151.03M | 129.62M | 138.66M | 106.67M | 86.21M | 94.52M | 86.22M | 129.05M | 84.95M | 451.97M | 10.86M | 33.35M | 17.19M | 23.10M | 19.03M | 13.86M | 38.54M | -42.96M | -47.00M |
Net Income Ratio | 0.09% | 0.78% | 0.33% | 1.89% | 1.57% | 0.62% | 1.97% | 3.53% | 4.71% | 4.63% | 4.67% | 4.04% | 3.28% | 4.38% | 5.10% | 7.14% | 4.73% | 29.92% | 2.43% | 1.90% | 0.92% | 1.23% | 1.26% | 1.14% | 2.87% | -3.73% | -5.20% |
EPS | 0.16 | 2.28 | 0.97 | 4.72 | 3.27 | 1.15 | 2.78 | 4.63 | 5.51 | 4.25 | 4.10 | 3.03 | 2.18 | 2.43 | 2.33 | 3.59 | 2.40 | 12.80 | 0.31 | 1.00 | 0.53 | 0.73 | 0.62 | 0.47 | 1.24 | -1.54 | -1.78 |
EPS Diluted | 0.16 | 2.28 | 0.97 | 4.51 | 3.14 | 1.11 | 2.71 | 4.53 | 5.42 | 4.17 | 4.03 | 3.01 | 2.16 | 2.37 | 2.23 | 3.42 | 2.34 | 10.86 | 0.26 | 0.81 | 0.53 | 0.72 | 0.61 | 0.46 | 1.24 | -1.54 | -1.78 |
Weighted Avg Shares Out | 25.78M | 24.56M | 25.04M | 23.33M | 23.18M | 24.87M | 26.69M | 27.05M | 27.39M | 30.48M | 33.78M | 35.25M | 39.61M | 38.94M | 36.99M | 35.97M | 35.37M | 35.31M | 35.14M | 33.45M | 32.14M | 31.76M | 30.78M | 29.47M | 31.01M | 27.87M | 26.39M |
Weighted Avg Shares Out (Dil) | 25.78M | 24.56M | 25.04M | 24.44M | 24.16M | 25.88M | 27.36M | 27.68M | 27.88M | 31.06M | 34.44M | 35.42M | 40.00M | 39.84M | 38.62M | 37.69M | 36.36M | 41.61M | 41.44M | 41.24M | 32.39M | 31.92M | 31.20M | 30.17M | 31.01M | 27.87M | 26.39M |
Magellan Healthcare Debuts High-Touch, High-Tech Collaborative Care Management Solution Powered by NeuroFlow
Magellan Health Opens Free Crisis Hotline to Support First Responders, Healthcare Workers and National Guard in Idaho
Magellan Healthcare Hosts Webinars in Support of National Depression and Mental Health Awareness and Screening Month
Magellan Rx Management's AIDS Drug Assistance Program Center of Excellence Expands Program That Significantly Improves Medication Adherence and Quality of Care for Patients with HIV
Magellan Health Provides Free Consultation Services and Referrals to Local Community Resources to Individuals Impacted by Hurricane Ida
Growth and Innovation Division at Magellan Health Announces New Appointments for Alisa Bahl, Ph.D. and Sean Gregory, Ph.D.
Magellan Healthcare Launches Clinically Proven Video Game Solution to Support Emotional Health for Youth
Magellan (MGLN) Unveils Program to Improve Members' Mental Health
4 Health Insurance Companies Poised for Growth in 2H21
Magellan Healthcare Launches eMbolden Resilience Program
Source: https://incomestatements.info
Category: Stock Reports